JUSTOZA-M

JUSTOZA-M

Mankind Specialities - Therapy Training​

Open Ended

Please enter your name below.

Open Ended

Please enter your HQ below.

Open Ended

Please enter your employee code.

​Patient Type: Newly Diagnosed T2DM ​

​

_{PLEASE CLICK ON LINK}​https://1drv.ms/v/s!AoKpB3GrKRCPiGbtp3UP0ySaY_2B?e=pNNnGG

Multiple Select

JUSTOZA-M suitable for which T2DM patient profile/s?

• Diabetes with or without ASCVD

• HIGH BASELINE HbA1C

• Uncontrolled T2DM patients

• Diabetes with CKD till Stage 3

• Overweight and Obese Diabetics

Multiple Select

use correct statement/s which explain MOA of Dapagliflozin (SGLT2i). (more than 1 option can be clicked)

• Act on PCT(Proximal Convoluted Tubule), nephron, kidney

• Block SGLT2 receptar

• reabsorption of glucose increases and thereby maintain right levels of Blood Glucose

• excretion of glucose increased hence reduce glucose level in body

Multiple Choice

Justoza-M offers benefits across the Cardio-Renal-Metabolic Continuum and shows reduction in CV mortality and HHF by ___ according to meta-analysis of >26000 patient data?

• 29%

• 39%

• 25%

• 17%

Multiple Select

Dapagliflozin in Justoza M shows CVOT benefits from which Trials?

• DECLARE TIMI 58

• DAPA HF

• DAPA CKD

• CANVAS

Multiple Choice

Match the Pair:

• 1- e

  2- c

  3- d

  4- a

  5- b

• 1- e

  2- a

  3- b

  4- c

  5- d

• 1- d

  2- b

  3- a

  4- c

  5- e

• 1- e

  2- d

  3- b

  4- a

  5- c

Multiple Select

SGLT2i are recommended as a preferred choice in diabetic patients irrespective of _____ parameter/s. (More than 1 option can tick)

• Baseline HbA1C levels

• Individualised A1c Target

• Kidney parameters

• Metformin use

Multiple Choice

Dapagliflozin in Justoza-M offers ___ FPG reduction

• 19.8 mg/dL

• 54 mg/dL

• 60.3 mg/dL

• 36.3 mg/dL

Multiple Choice

--- proportion of patients on Justoza-M achieved weight ;loss reduction >=5% compared to 2.5% with SU+Metformin combination.

• 22.3%

• 33.3%

• 22.2%

• 23.2%

Multiple Choice

Match the Pairs and choose right option

• 1-a

  2-c

  3-b

• 1-b

  2-c

  3-a

• 1-b

  2-a

  3-c

• 1-c

  2-b

  3-a

Multiple Select

API DMF Grade dapagliplozin in Justoza-M, comes from facilities approved from ---certified plants. (more than 1 tick possible)

• ADA

• EU GMP

• WHO

• USFDA

Multiple Choice

Renal threshold increased to --- of glucose in T2DM patient

• 140 mg/dl

• 160 mg/dl

• 240mg/dl

• 280 mg/dl

Multiple Select

selective SGLT2i like dapagliflozin in Justoza-M results in. (more than 1 tick possible)

• Inhibition of renal glucose reabsorption

• Increased renal Excretion of glucose

• Urinary loss of glucose and calories

• Weight loss

• Decrease insulin resistance secretion

​Thank you

All the best for

"Giant Leap​"